<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nodgo</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал детской гематологии и онкологии (РЖДГиО)</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Pediatric Hematology and Oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-1267</issn><issn pub-type="epub">2413-5496</issn><publisher><publisher-name>LTD “Graphica”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21682/2311-1267-2020-7-3-125-131</article-id><article-id custom-type="elpub" pub-id-type="custom">nodgo-636</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Атипичная презентация метастатических очагов у пациентов с 4S стадией нейробластомы группы наблюдения: описание клинического случая</article-title><trans-title-group xml:lang="en"><trans-title>Atypical presentation of metastatic disease in patients with stage 4S neuroblastoma of the observation group: description of the clinical case</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9625-8625</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лилия Андреевна Смирнова, врач-ординатор по специальности «детская онкология»</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Resident in the Specialty “Children's Oncology”</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">Liliya.smirnova94@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3704-8783</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Качанов</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kachanov</surname><given-names>D. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, заведующий отделением клинической онкологии, заместитель директора Института онкологии, радиологии и ядерной медицины</p><p>117997, Москва, ул. Саморы Машела, 1</p><p>SPIN-код: 9878-5540</p></bio><bio xml:lang="en"><p>Dr. of Sci. (Med.), Head of the Department of Clinical Oncology, Deputy Director of the Institute of Oncology, Radiology and Nuclear Medicine</p><p>1 Samory Mashela St., Moscow, 117997</p><p>SPIN-code: 9878-5540</p></bio><email xlink:type="simple">Denis.Kachanov@fccho-moscow.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8129-0545</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербаков</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherbakov</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Врач рентгенологического отделения</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Physician of Radiology Department</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">Alexey.Shcherbakov@fccho-moscow.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1387-209X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ахаладзе</surname><given-names>Д. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Akhaladze</surname><given-names>D. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, руководитель группы торакоабдоминальной хирургии</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Cand. of Sci. (Med.), Head of Thoracoabdominal Surgery Group</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">Dmitry.Ahaladze@fccho-moscow.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4042-0125</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Телешова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Teleshova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Врач-детский онколог отделения клинической онкологии</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Pediatric Oncologist Department of Clinical Oncology</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">teleshova_m@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6158-2222</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ликарь</surname><given-names>Ю. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Likar</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, заведующий отделением позитронно-эмиссионной томографии и радионуклидной диагностики</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Dr. of Sci. (Med.), Head of Positron Emission Tomography and Radionuclide Diagnostics Department</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">Yury.Likar@fccho-moscow.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3767-4477</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шаманская</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shamanskaya</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, руководитель отдела изучения эмбриональных опухолей Института онкологии, радиологии и ядерной медицины</p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><bio xml:lang="en"><p>Cand. of Sci. (Med.), Head of the Department of Embryonic Tumors Research of the Institute of Oncology, Radiology and Nuclear Medicine</p><p>1 Samory Mashela St., Moscow, 117997</p></bio><email xlink:type="simple">shamanskaya.tatyana@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>09</month><year>2020</year></pub-date><volume>7</volume><issue>3</issue><fpage>125</fpage><lpage>131</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смирнова Л.А., Качанов Д.Ю., Щербаков А.П., Ахаладзе Д.Г., Телешова М.В., Ликарь Ю.Р., Шаманская Т.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Смирнова Л.А., Качанов Д.Ю., Щербаков А.П., Ахаладзе Д.Г., Телешова М.В., Ликарь Ю.Р., Шаманская Т.В.</copyright-holder><copyright-holder xml:lang="en">Smirnova L.A., Kachanov D.Y., Shcherbakov A.P., Akhaladze D.G., Teleshova M.V., Likar Y.N., Shamanskaya T.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nodgo.org/jour/article/view/636">https://journal.nodgo.org/jour/article/view/636</self-uri><abstract><p>Для самой частой экстракраниальной солидной злокачественной опухоли детского возраста – нейробластомы (НБ) характерно наличие 2 метастатических форм (4 и 4S стадии). При 4S стадии отмечается метастазирование в печень, кожу и минимальное поражение костного мозга (КМ). Определенные редкие для НБ локализации метастазов (плевра, яички и др.) могут не ухудшать прогноз у детей первого года жизни при отсутствии выраженного метастатического поражения КМ и костей скелета. В статье представлено описание клинического случая забрюшинной НБ с атипичным метастазированием в плевру у ребенка первых месяцев жизни с благоприятным исходом при проведении минимального объема химиотерапии.</p></abstract><trans-abstract xml:lang="en"><p>The most common extracranial solid malignant tumor of childhood – neuroblastoma (NB) is characterized by the presence of two metastatic forms (stages 4 and 4S). Stage 4S is described to have metastatic spread to the liver, skin, and minimal bone marrow invasion. Certain rare localisations of NB metastases (pleura, testicles, and others) may not worsen the prognosis in children of the first year of life in the absence of severe bone marrow invasion and metastases to the skeletal bones. The article describes a clinical case of retroperitoneal NB with atypical metastasis to the pleura in a child of the first months of life with a favorable outcome with a minimum amount of chemotherapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нейробластома</kwd><kwd>4S стадия</kwd><kwd>дети</kwd><kwd>группа наблюдения</kwd><kwd>метастазы</kwd><kwd>компьютерная томография</kwd><kwd>сцинтиграфия с 123I-метайодбензилгуанидином</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neuroblastoma</kwd><kwd>children</kwd><kwd>stage 4S</kwd><kwd>observation group</kwd><kwd>metastases</kwd><kwd>computed tomography</kwd><kwd>scintigraphy with</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шаманская Т.В., Качанов Д.Ю., Феоктистова Е.В., Терещенко Г.В., Ликарь Ю.Н., Муфтахова Г.М., Талыпов С.Р., Варфоломеева С.Р. Гетерогенность 4S стадии нейробластомы: мультидисциплинарный взгляд. Российский журнал детской гематологии и онкологии 2017;4(1):83–8. doi: 10.17650/2311-1267-2017-4-1-83-88.</mixed-citation><mixed-citation xml:lang="en">Shamanskaya T.V., Kachanov D.Yu., Feoktistova E.V., Tereshchenko G.V., Likar Yu.N., Muftakhova G.M., Talypov S.R., Varfolomeeva S.R. Heterogeneity of neuroblastoma stage 4S: a multidisciplinary view. Rossiyskiy zhurnal detskoy gematologii i onkologii = Russian Journal of Pediatric Hematology and Oncology 2017;4(1):83–8. (In Russ.). doi: 10.17650/2311-1267-2017-4-1-83-88.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castleberry R.P., Bernardi B.D., Evans A. E., Favrot M.C., Hedborg F., Kaneko M., Kemshead J., Lampert F., Lee R.J., Look A.T., Pearson A.D., Philip T., Roald B., Sawada T., Seeger R.C., Tsuchida Y., Voute P.A. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11(8):1466–77. doi: 10.1200/JCO.1993.11.8.1466.</mixed-citation><mixed-citation xml:lang="en">Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castleberry R.P., Bernardi B.D., Evans A. E., Favrot M.C., Hedborg F., Kaneko M., Kemshead J., Lampert F., Lee R.J., Look A.T., Pearson A.D., Philip T., Roald B., Sawada T., Seeger R.C., Tsuchida Y., Voute P.A. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11(8):1466–77. doi: 10.1200/JCO.1993.11.8.1466.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pritchard J., Hickman J.A. Why does stage 4s neuroblastoma regress spontaneously? Lancet 1994;344(8926):869–70. doi: 10.1016/S0140-6736(94)92834-7.</mixed-citation><mixed-citation xml:lang="en">Pritchard J., Hickman J.A. Why does stage 4s neuroblastoma regress spontaneously? Lancet 1994;344(8926):869–70. doi: 10.1016/S0140-6736(94)92834-7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">van Noesel M.M., Hählen K., Hakvoort-Cammel F.G., Egeler R.M. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer 1997;80(5):834–43. PMID: 9307181.</mixed-citation><mixed-citation xml:lang="en">van Noesel M.M., Hählen K., Hakvoort-Cammel F.G., Egeler R.M. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies. Cancer 1997;80(5):834–43. PMID: 9307181.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Monclair T., Brodeur G.M., Ambros P.F., Brisse H.J., Cecchetto G., Holmes K., Kaneko M., London W.B., Matthay K.K., Nuchtern J.G., von Schweinitz D., Simon T., Cohn S.L., Pearson A.D.J.; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009;27(2):298–303. doi: 10.1200/JCO.2008.16.6876.</mixed-citation><mixed-citation xml:lang="en">Monclair T., Brodeur G.M., Ambros P.F., Brisse H.J., Cecchetto G., Holmes K., Kaneko M., London W.B., Matthay K.K., Nuchtern J.G., von Schweinitz D., Simon T., Cohn S.L., Pearson A.D.J.; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009;27(2):298–303. doi: 10.1200/JCO.2008.16.6876.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pepper W.A. A study of congenital sarcoma of the liver and suprarenal with report of a case. Am J Med Sci 1901;121(3):287.</mixed-citation><mixed-citation xml:lang="en">Pepper W.A. A study of congenital sarcoma of the liver and suprarenal with report of a case. Am J Med Sci 1901;121(3):287.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rothenberg A.B., Berdon W.E., D’Angio G.J., Yamashiro D.J., Cowles R.A. Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison. Pediatr Radiol 2009;39(2):155–60. doi: 10.1007/s00247-008-1062-z.</mixed-citation><mixed-citation xml:lang="en">Rothenberg A.B., Berdon W.E., D’Angio G.J., Yamashiro D.J., Cowles R.A. Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison. Pediatr Radiol 2009;39(2):155–60. doi: 10.1007/s00247-008-1062-z.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Качанов Д.Ю., Шаманская Т.В., Муфтахова Г.М., Варфоломеева С.Р. Нейробластома 4S стадии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2014;13(2):9–19.</mixed-citation><mixed-citation xml:lang="en">Kachanov D.Yu., Shamanskaya T.V., Muftakhova G.M., Varfolomeeva S.R. Neuroblastoma stage 4S. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/Oncology and Immunopathology 2014;13(2):9–19. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hero B., Simon T., Horz S., Berthold F. Metastatic neuroblastoma in infancy: What does the pattern of metastases contribute to prognosis? Med Pediatr Oncol 2000;35:683–7. doi: 10.1002/1096-911x(20001201)35:6&lt;683::aid-mpo43&gt;3.0.co;2-f.</mixed-citation><mixed-citation xml:lang="en">Hero B., Simon T., Horz S., Berthold F. Metastatic neuroblastoma in infancy: What does the pattern of metastases contribute to prognosis? Med Pediatr Oncol 2000;35:683–7. doi: 10.1002/1096-911x(20001201)35:6&lt;683::aid-mpo43&gt;3.0.co;2-f.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Simon T., Hero B., Schulte J.H., Deubzer H., Hundsdoerfer P., von Schweinitz D., Fuchs J., Schmidt M., Prasad V., Krug B., Timmermann B., Leuschner I., Fischer M., Langer T., Astrahantseﬀ K., Berthold F., Lode H., Eggert A. 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors. Klin Pädiatr 2017;229(3):147–67. doi:10.1055/s-0043-103086.</mixed-citation><mixed-citation xml:lang="en">Simon T., Hero B., Schulte J.H., Deubzer H., Hundsdoerfer P., von Schweinitz D., Fuchs J., Schmidt M., Prasad V., Krug B., Timmermann B., Leuschner I., Fischer M., Langer T., Astrahantseﬀ K., Berthold F., Lode H., Eggert A. 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors. Klin Pädiatr 2017;229(3):147–67. doi:10.1055/s-0043-103086.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Simon T., Hero B., Berthold F. Testicular and paratesticular involvement by metastatic neuroblastoma. Cancer 2000;88(11):2636–41. doi: 10.1002/1097-0142(20000601)88:11&lt;2636:AID-CNCR28&gt;3.0.CO;2-K.</mixed-citation><mixed-citation xml:lang="en">Simon T., Hero B., Berthold F. Testicular and paratesticular involvement by metastatic neuroblastoma. Cancer 2000;88(11):2636–41. doi: 10.1002/1097-0142(20000601)88:11&lt;2636:AID-CNCR28&gt;3.0.CO;2-K.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Moser O., Scheurlen W., Leipold A., Dilloo D., Hero B. Muscle involvement in neuroblastoma with spontaneous regression. Proceedings of Advances in Neuroblastoma Research Congress. 13–16 May 2014. Cologne, Germany. Abstr. POC024. Pp. 237–238.</mixed-citation><mixed-citation xml:lang="en">Moser O., Scheurlen W., Leipold A., Dilloo D., Hero B. Muscle involvement in neuroblastoma with spontaneous regression. Proceedings of Advances in Neuroblastoma Research Congress. 13–16 May 2014. Cologne, Germany. Abstr. POC024. Pp. 237–238.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Meyers P.A., Heller G., Healey J.H., Huvos A., Applewhite A., Sun M., LaQuaglia M. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993;11(3):449–53. doi: 10.1200/jco.1993.11.3.449.</mixed-citation><mixed-citation xml:lang="en">Meyers P.A., Heller G., Healey J.H., Huvos A., Applewhite A., Sun M., LaQuaglia M. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993;11(3):449–53. doi: 10.1200/jco.1993.11.3.449.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Жилкин И.В., Ахаладзе Д.Г., Литвинов Д.В., Ускова Н.Г., Тихонова М.В., Грачев Н.С., Карачунский А.И. Метастатическое поражение легких при остеосаркоме. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2019;18(4):127–35. doi: 10.24287/1726-1708-2019-18-4-127-135.</mixed-citation><mixed-citation xml:lang="en">Zhilkin I.V., Akhaladze D.G., Litvinov D.V., Uskova N.G., Tikhonova M.V., Grachev N.S., Karachunskiy A.I. Metastatic lung disease in osteosarcoma. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/Oncology and Immunopathology 2019;18(4):127–35. (In Russ.). doi: 10.24287/1726-1708-2019-18-4-127-135.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bosma S.E., Rueten‐Budde A.J., Lancia C., Ranft A., Dirksen U., Krol A.D., Gelderblom H., van de Sande M., Dijkstra P., Fiocco M. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model for Ewing sarcoma. Pediatr Blood Cancer 2019;66(11):e27943. doi: 10.1002/pbc.27943.</mixed-citation><mixed-citation xml:lang="en">Bosma S.E., Rueten‐Budde A.J., Lancia C., Ranft A., Dirksen U., Krol A.D., Gelderblom H., van de Sande M., Dijkstra P., Fiocco M. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model for Ewing sarcoma. Pediatr Blood Cancer 2019;66(11):e27943. doi: 10.1002/pbc.27943.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
